News, Uncategorized
Promising results from a Phase 1 clinical trial of the ChAdOx1 RVF vaccine against Rift Valley fever in humans.
This first evaluation of the vaccine in humans published in The Lancet Infectious Diseases was done in the United Kingdom with the aim of assessing the safety and immune response generated by a single shot of the ChAdOx1 RVF vaccine. A total of 15 volunteers were recruited into the study and three immunised with a […]
Read More